Results 31 to 40 of about 3,093,388 (334)

OR18-05 Interleukin 21 Drives The Development Of Autoimmune Diabetes Mellitus During Immune Checkpoint Inhibitor Cancer Therapy [PDF]

J Endocr Soc, 2023
Jessica Ortega, Lauren N Scott, Sarah Wang, Shile Zhang, Ho-Chung Chen, Nicole Huang, Melissa G. Lechner   +6 more
europepmc   +2 more sources

Role of interleukin-21 in primary knee osteoarthritis: a clinical, laboratory and radiological study in Assiut Governorate

Al-Azhar Assiut Medical Journal
Background and aim Primary osteoarthritis (OA) is the most frequent arthritis, causing mobility impairment, joint deformities, and compromising quality of life.
Mohamed I.M. Abdelkareem, Awad S. Abbas, Ahmed M. Salem, Rehab A.E. Elsayed   +3 more
doaj   +2 more sources

Probiotic Supplementation Improves Glucose Homeostasis and Modulates Interleukin (IL)-21 and IL-22 Levels in Pediatric Patients with Type 1 Diabetes: A Randomized Placebo-Controlled Trial

Metabolites
Background: Probiotics alter gut microbiota and have beneficial effects on immune homeostasis. The role of probiotics in diabetes has been shown in some studies.
Amira Abdel Moneam Adly, Eman Abdel Rahman Ismail, Mahasen Mohamed Abd-Elgawad, Nouran Yousef Salah   +3 more
doaj   +2 more sources

Circulating HIV-Specific Interleukin-21+CD4+ T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions [PDF]

Immunity, 2016
Bruce Schultz, Jeffrey E. Teigler, Franco Pissani, Alexander F. Oster, Gregory Kranias, Galit Alter, Mary Marovich, Michael A. Eller, Ulf Dittmer, Merlin L. Robb, Jérôme H. Kim, Nelson L. Michael, Diane L. Bolton, Hendrik Streeck   +13 more
openalex   +2 more sources

Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection. [PDF]

J Infect Dis, 2018
Paidipally P, Tripathi D, Van A, Radhakrishnan RK, Dhiman R, Venkatasubramanian S, Devalraju KP, Tvinnereim AR, Valluri VL, Vankayalapati R.   +9 more
europepmc   +2 more sources

Modeling the response to interleukin-21 to inform natural killer cell immunotherapy. [PDF]

Immunol Cell Biol
Nayak I, Biondo R, Stewart WC, Fulton RJ, Möker N, Zhang C, Khakoo SI, Das J.   +7 more
europepmc   +2 more sources

Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways. [PDF]

Exp Hematol Oncol
He B, Chen H, Wu J, Qiu S, Mai Q, Zeng Q, Wang C, Deng S, Cai Z, Liu X, Xuan L, Li C, Zhou H, Liu Q, Xu N.   +14 more
europepmc   +2 more sources

IL-21–Deficient T Follicular Helper Cells Support B Cell Responses Through IL-27 in Patients With Chronic Hepatitis B

Frontiers in Immunology, 2021
Chronic Hepatitis B (CHB) affects over 350 million people worldwide. Current treatment does result in reduced complications; however, a cure (development of antibodies to the S antigen) is not achieved, requiring life-long therapy.
Arshi Khanam, Natarajan Ayithan, Lydia Tang, Bhawna Poonia, Shyam Kottilil   +4 more
doaj   +1 more source

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA⁺ B cells. [PDF]

Mol Cancer
Xie Y, Huang Y, Li ZY, Jiang W, Shi NX, Lu Y, Cao G, Yin Z, Lin XJ.   +8 more
europepmc   +3 more sources

T follicular helper cells, interleukin-21 and systemic lupus erythematosus [PDF]

Rheumatology, 2016
Noémie Gensous, Nathalie Schmitt, Christophe Richez, Hideki Ueno, Patrick Blanco   +4 more
openalex   +2 more sources